A revolutionary study by Yuvan Research reveals the successful reversal of biological age in rats by over 50%, marking the first instance of cross-species epigenetic transfer. The results of the study were published in GeroScience. The therapy, dubbed E5, utilises extracellular nanoparticles from young porcine plasma, injecting them into elderly rats and yielding significant youthfulness within days. The implications of these findings suggest that similar results in humans could mean reverting an 80-year-old to the biological age of 26. The research broadens the horizons of ageing biology and could have applications beyond rats.
- Revolutionary study by Yuvan Research reverses aging in rats by over 50% using young pig plasma nanoparticles.
- Results imply similar therapy could revert 80-year-old human to age 26 biologically.
- Potential applications beyond humans in veterinary medicine and conservation biology.
Extracellular nanoparticles: the elixir of youthfulness?
Extracellular nanoparticles derived from young plasma of another species – pigs, in this instance – are at the heart of the E5 therapeutic developed by Harold Katcher and his colleagues at Yuvan Research. These na
